March 30 (Reuters) - IMV Inc IMV.TO :
* IMV INC. PROVIDES UPDATES ON THE DEVELOPMENT OF DPX-COVID-19 VACCINE AND ONGOING BUSINESS AND CLINICAL OPERATIONS
* IMV INC - IT IS ANTICIPATED THAT COVID-19 PANDEMIC CRISIS WILL IMPACT ONGOING TRIAL ACTIVITIES ACROSS INDUSTRY
* IMV INC - DRUG SUPPLY IS NOT EXPECTED TO BE IMPACTED AT THIS TIME
* IMV INC - HAS INITIATED DISCUSSIONS WITH HEALTH CANADA IN PREPARATION FOR A CLINICAL TRIAL APPLICATION
* IMV - MEETING WITH HEALTH CANADA IS BEING SCHEDULED IN WEEK OF APRIL 20 WITH GOAL TO INITIATE CLINICAL STUDY FOR DPX-COVID-19 VACCINE IN SUMMER OF 2020